Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine + Cisplatin in Metastatic Nasopharyngeal Carcinoma
NCT02608073Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2004
- Primary completion
- Nov 2009
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of capecitabine in nasopharyngeal carcinoma (NPC), sponsored by Roche. Started Nov 2004; status: completed.
02
Drugs
capecitabine
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02608073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02608073.